| |
| Issue |
Title |
| |
| No 22 (2024) |
Late diagnosis of spinal muscular atrophy, primary symptoms of the disease according to the patient registry of the SMA Families Foundation |
Abstract
PDF (Rus)
|
|
S. В. Artemyeva, Yu. О. Papina, O. Yu. Germanenko |
| |
| No 21 (2023) |
Features of the clinical course of neurodegenerative brain disease caused by mutations in the neurophacitis and succinate dehydrogenase gene: clinical case |
Abstract
PDF (Rus)
|
|
E. A. Tkachuk, T. A. Astakhova, L. V. Rychkova, O. V. Bugun |
| |
| No 2 (2021) |
Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease |
Abstract
PDF (Rus)
|
|
N. V. Titova, A. A. Portupeev |
| |
| No 19 (2020) |
Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia |
Abstract
PDF (Rus)
|
|
O. S. Levin, A. Sh. Chimagomedova, O. V. Yakovleva |
| |
| No 19 (2020) |
Diagnosis and treatment for frontotemporal degenerations |
Abstract
PDF (Rus)
|
|
D. A. Grishina, Yu. A. Shpilyukova, A. B. Lokshina, E. Yu. Fedotova |
| |
| No 19 (2020) |
Alzheimer’s disease: clinical management errors |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 8 (2020) |
Review of Mucuna pruriens L. therapeutic potential for Parkinson’s disease |
Abstract
PDF (Rus)
|
|
A. S. Panova, D. S. Dergachev, M. A. Subotyalov, V. D. Dergachev |
| |
| No 2 (2020) |
Heterogeneity of speech disorders in Parkinson’s disease: potential for classification, diagnostics and therapy |
Abstract
PDF (Rus)
|
|
E. E. Vasenina, O. S. Levin |
| |
| No 10 (2015) |
Atypical parkinsonism. Lecture |
Abstract
PDF (Rus)
|
|
V. L. Golubev |
| |
| No 18 (2015) |
Diagnosis and treatment of Alzheimer's disease: facets of the problem |
Abstract
PDF (Rus)
|
|
Editorial Article |
| |
| 1 - 10 of 10 Items |
|
